Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2016

Planlagt Fastgjort Låst Flyttet Genmab
2.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #2622

    royal: ja, for Pollux er også rev+dex, som altså kan have 8 mdr. længere PFS. 1. halvår bliver så nok først slut juni.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #2623

      Synes stadig det er forkasteligt at CEO plus en anden ledende medarbejde kunne sælge aktier den 30/12, når de helt sikkert viste at man ikke indrullede alle patienter. Så fik de lige solgt til kurs 18 og kort tid efter kunne vi andre sælge til kurs 4
      !! Not nice - not nice at all 😞

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Skyggen
        wrote on sidst redigeret af
        #2624

        Mange tak for svar 😄

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #2625

          Lever-tox problemerne blev lidt negligeret da data blev præsenteret, men nu har man hentet penge, så spørgsmålet er hvorledes synes er næste gang vi hører noget 🙂

          1 Reply Last reply
          0
          • J Offline
            J Offline
            Jedi
            wrote on sidst redigeret af
            #2626

            Helt enig Sukker, rigtig skidt med den manøvre omkring nytår 😞 - men de kan gøre noget af skaden god igen ved at få en kandidat kørt helt frem. Spændende hvad de kan komme op med efter fornyet kapital, vi må krydse fingre
            🙂

            1 Reply Last reply
            0
            • J Offline
              J Offline
              Jedi
              wrote on sidst redigeret af
              #2627

              Vedr. rekruttering til Castor og Pollux sagde Jan på CC efter Q4, 2014 sådan: Thanks, Michael for the questions. Let me start with question two actually, the trial, the Phase 3 trial with Revlimid-Idelalisib [ph]or without daratumumab is recruiting very, very rapidly and much ahead of schedule and hopefully we can give you soon recruitment updates on that study. And thus far the recruitment has exceeded all of Janssen’s expectations by a lot, I can tell you. Also the Velcade-dex-dara combination

              1 Reply Last reply
              0
              • J Offline
                J Offline
                Jedi
                wrote on sidst redigeret af
                #2628

                Access to this page has been denied

                px-captcha

                favicon

                (seekingalpha.com)

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  Jedi
                  wrote on sidst redigeret af
                  #2629

                  se under Q & A fra Michael Novod

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    Jedi
                    wrote on sidst redigeret af
                    #2630

                    og glem at der står Idelalisib, det hører ikke til der....

                    1 Reply Last reply
                    0
                    • O Offline
                      O Offline
                      OHW
                      wrote on sidst redigeret af
                      #2631

                      hmmm...det ser godt nok ikke ud til, at noget vil trække os i ATH i dag..

                      1 Reply Last reply
                      0
                      • royalR Offline
                        royalR Offline
                        royal
                        wrote on sidst redigeret af
                        #2632

                        Tak Bulder.

                        1 Reply Last reply
                        0
                        • dingleberryD Offline
                          dingleberryD Offline
                          dingleberry
                          wrote on sidst redigeret af
                          #2633

                          wauw - check lige IMGN her i åbningen!

                          1 Reply Last reply
                          0
                          • dingleberryD Offline
                            dingleberryD Offline
                            dingleberry
                            wrote on sidst redigeret af
                            #2634

                            og store prygl til GILD som forventet

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #2635

                              IMGN av - hvad sker der?

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                MUFC_Oberanven
                                wrote on sidst redigeret af
                                #2636

                                ImmunoGen Reports Wider Q3 Loss Vs. Street, Misses on Revenue; Lowers FY16 Revenue Outlook Below Forecasts<IMGN.OQ> - MT Newswires

                                29-Apr-2016 13:15:18

                                07:09 AM EDT, 04/29/2016 (MT Newswires) -- ImmunoGen (IMGN) reported Friday that
                                for Q3 ended March 31, its loss was wider than expected, and revenue fell short
                                of analysts' estimates; it also lowered its revenue guidance for fiscal 2016
                                below Street forecasts.

                                The clinical-stage biotechnology company posted Q3 net loss of $31.9 million, or
                                $0

                                1 Reply Last reply
                                0
                                • dingleberryD Offline
                                  dingleberryD Offline
                                  dingleberry
                                  wrote on sidst redigeret af
                                  #2637

                                  det kan vist ikke betale sig at skuffe forventninger i det her marked....

                                  1 Reply Last reply
                                  0
                                  • dingleberryD Offline
                                    dingleberryD Offline
                                    dingleberry
                                    wrote on sidst redigeret af
                                    #2638

                                    IMGN justerede guidance - 2016 guidance for its net loss is now expected to be between $135 million and $140 million, versus previous estimate of $120 million and $125 million

                                    1 Reply Last reply
                                    0
                                    • dingleberryD Offline
                                      dingleberryD Offline
                                      dingleberry
                                      wrote on sidst redigeret af
                                      #2639

                                      så ikke noget med klinikken

                                      1 Reply Last reply
                                      0
                                      • dingleberryD Offline
                                        dingleberryD Offline
                                        dingleberry
                                        wrote on sidst redigeret af
                                        #2640

                                        hold da helt kæft, hvor er US sur!

                                        1 Reply Last reply
                                        0
                                        • A Offline
                                          A Offline
                                          andreas961
                                          wrote on sidst redigeret af
                                          #2641

                                          kan det anbefales at købe genmab aktier nu?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger